These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11853019)

  • 21. Elevated Hippocampal Cholinergic Neurostimulating Peptide precursor protein (HCNP-pp) mRNA in the amygdala in major depression.
    Bassi S; Seney ML; Argibay P; Sibille E
    J Psychiatr Res; 2015 Apr; 63():105-16. PubMed ID: 25819500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-localization of hippocampal cholinergic neurostimulating peptide precursor with collapsin response mediator protein-2 at presynaptic terminals in hippocampus.
    Kato D; Mitake S; Mizuno M; Kanamori T; Suzuki T; Ojika K; Matsukawa N
    Neurosci Lett; 2012 May; 517(2):92-7. PubMed ID: 22542739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease.
    George AJ; Holsinger RM; McLean CA; Tan SS; Scott HS; Cardamone T; Cappai R; Masters CL; Li QX
    Neurobiol Aging; 2006 Apr; 27(4):614-23. PubMed ID: 15941609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of hippocampal cholinergic neurostimulating peptide in heterozygous transgenic mice increases the amount of ChAT in the medial septal nucleus.
    Uematsu N; Matsukawa N; Kanamori T; Arai Y; Sagisaka T; Toyoda T; Yoshida M; Ojika K
    Brain Res; 2009 Dec; 1305():150-7. PubMed ID: 19815004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCNP precursor protein transgenic mice display a depressive-like phenotype in old age.
    Matsukawa N; Furuya Y; Ogura H; Ojika K
    Brain Res; 2010 Aug; 1349():153-61. PubMed ID: 20599825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hippocampal Cholinergic Neurostimulating Peptide Suppresses Acetylcholine Synthesis in T Lymphocytes.
    Saito Y; Mashimo M; Nobeyama A; Murakami K; Fujii T
    Biol Pharm Bull; 2018; 41(10):1611-1614. PubMed ID: 30270332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano bodies.
    Mitake S; Ojika K; Katada E; Otsuka Y; Matsukawa N; Fujimori O
    Neuropathol Appl Neurobiol; 1995 Feb; 21(1):35-40. PubMed ID: 7770119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Function of HCNP/HCNP precursor in memory formation].
    Matsukawa N; Ojika K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):219-27. PubMed ID: 17240848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of DNA variations in promoter region of HCNP gene with Alzheimer's disease.
    Okita K; Matsukawa N; Maki M; Nakazawa H; Katada E; Hattori M; Akatsu H; Borlongan CV; Ojika K
    Biochem Biophys Res Commun; 2009 Feb; 379(2):272-6. PubMed ID: 19101508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible implication of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano body formation.
    Mitake S; Katada E; Otsuka Y; Matsukawa N; Iwase T; Tsugu T; Fujimori O; Ojika K
    Neuropathol Appl Neurobiol; 1996 Oct; 22(5):440-5. PubMed ID: 8930956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology.
    Goumon Y; Angelone T; Schoentgen F; Chasserot-Golaz S; Almas B; Fukami MM; Langley K; Welters ID; Tota B; Aunis D; Metz-Boutigue MH
    J Biol Chem; 2004 Mar; 279(13):13054-64. PubMed ID: 14724289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease.
    Tsugu Y; Ojika K; Matsukawa N; Iwase T; Otsuka Y; Katada E; Mitake S
    Eur J Neurol; 1998 Nov; 5(6):561-569. PubMed ID: 10210891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMDA receptor activation enhances the release of a cholinergic differentiation peptide (HCNP) from hippocampal neurons in vitro.
    Ojika K; Tsugu Y; Mitake S; Otsuka Y; Katada E
    Brain Res Dev Brain Res; 1998 Mar; 106(1-2):173-80. PubMed ID: 9555001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid receptor gene expression is unaltered in hippocampal neurons in Alzheimer's disease.
    Seckl JR; French KL; O'Donnell D; Meaney MJ; Nair NP; Yates CM; Fink G
    Brain Res Mol Brain Res; 1993 May; 18(3):239-45. PubMed ID: 8497185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippocampal Cholinergic Neurostimulating Peptide as a Possible Modulating Factor against Glutamatergic Neuronal Disability by Amyloid Oligomers.
    Sato T; Ohi Y; Kato D; Mizuno M; Takase H; Kanamori T; Borlongan CV; Haji A; Matsukawa N
    Cell Transplant; 2017 Sep; 26(9):1542-1550. PubMed ID: 29113468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific binding of 125I-hippocampal cholinergic neurostimulating peptide (HCNP) to rat brain membranes: characterization and regional distribution.
    Morishita M; Otsuka Y; Matsukawa N; Suzuki H; Nakazawa H; Maki M; Katou H; Ueda R; Ojika K
    Brain Res; 2003 Mar; 965(1-2):194-202. PubMed ID: 12591138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of hippocampal phosphatidylethanolamine-binding protein in morphine dependence and withdrawal.
    Wei QH; Wu N; Bian JM; Chen Y; Su RB; Li J
    Addict Biol; 2013 Mar; 18(2):230-40. PubMed ID: 21967037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats.
    Singh M; Meyer EM; Simpkins JW
    Endocrinology; 1995 May; 136(5):2320-4. PubMed ID: 7720680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex.
    Chandrasekaran K; Hatanpää K; Brady DR; Stoll J; Rapoport SI
    Brain Res; 1998 Jun; 796(1-2):13-9. PubMed ID: 9689449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration and characterization of hippocampal cholinergic neurostimulating peptide (HCNP) processing enzyme activity in rat hippocampus.
    Otsuka Y; Ojika K
    Neurochem Res; 1996 Mar; 21(3):369-76. PubMed ID: 9139244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.